agilon health (NYSE:AGL) Shares Gap Up – Here’s Why

agilon health, inc. (NYSE:AGLGet Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $2.73, but opened at $3.05. agilon health shares last traded at $2.96, with a volume of 367,974 shares trading hands.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Benchmark restated a “buy” rating and set a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Citigroup reiterated a “sell” rating and issued a $2.50 price target (down previously from $7.00) on shares of agilon health in a report on Tuesday, October 29th. Royal Bank of Canada reissued an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research note on Wednesday, October 2nd. Finally, Evercore ISI reduced their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Three investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $7.81.

Read Our Latest Report on agilon health

agilon health Trading Up 5.5 %

The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of -3.97 and a beta of 0.60. The company has a fifty day simple moving average of $3.36 and a 200-day simple moving average of $5.03.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business earned ($0.04) earnings per share. The firm’s revenue was up 38.7% compared to the same quarter last year. On average, research analysts forecast that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Insider Buying and Selling at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its stake in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares during the period. AQR Capital Management LLC increased its stake in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC raised its holdings in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares in the last quarter. Capital International Investors boosted its position in agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares during the last quarter. Finally, Simplicity Wealth LLC grew its stake in agilon health by 145.1% in the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after purchasing an additional 15,515 shares in the last quarter.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.